iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 174

Identifiers

  • Canonical SMILES:
    CN1CCN(CC1)c1ccc(OCCCc2sc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)c(F)c1
  • IUPAC name:
    2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[2-fluoro-4-(4-methylpiperazin-1-yl)phenoxy]propyl]-1,3-thiazole-4-carboxylic acid
  • InChi:
    InChI=1S/C35H35FN6O4S2/c1-40-15-17-41(18-16-40)23-11-12-28(26(36)20-23)46-19-5-10-30-31(33(44)45)38-35(48-30)42-14-13-22-6-4-7-24(25(22)21-42)32(43)39-34-37-27-8-2-3-9-29(27)47-34/h2-4,6-9,11-12,20H,5,10,13-19,21H2,1H3,(H,44,45)(H,37,39,43)
  • InChiKey:
    ACEUUKOOFDTVPH-UHFFFAOYSA-N

External links


46836865

External search

Bibliography (1)

Publication Name
Jonathon Bayldon Baell, Chinh Thien Bui, Peter Colman, Peter Czabotar, Danette A. Dudley, Wayne J. Fairbrother, John A. Flygare, Guillaume Laurent Lassene, Chudi Ndubaku, George Nikolakopoulos, Brad Edmund Sleebs, Brian John Smith, Keith Geoffrey Watson, Steven W. Elmore, Lisa A. Hasvold, Andrew M. Petros, Andrew J. Souers, Zhi-Fu Tao, Le Wang, Xilu Wang, Kurt Deshayes, Genentech, Inc., The Walter And Eliza Hall Institute Of Medical Research, Abbott Laboratories. . Heterocyclic compounds and methods of use None. 93

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
BCL2-Like / BAX 6.81 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 686.21 g/mol
HBA 10
HBD 2
HBA + HBD 12
AlogP 4.96
TPSA 111.13
RB 10
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
WO2010080503 93 BCL2
P10415

Biochemical assay Time-Resolved FRET pKi (inhibition constant, -log10) 6.81
Ta Structure Name Drugbank ID
0.5256 (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE DB07406
0.4671 N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide DB02295
0.4320 JTK-853 DB13095
0.4232 Acotiamide DB12482
0.4197 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE DB08192
0.4103 Ziritaxestat DB15403
0.4056 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea DB07362
0.4038 N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide DB08677
0.4025 3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide DB07359
0.4013 MK-5108 DB12556
0.3973 2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide DB08118
0.3951 4SC-203 DB12669
0.3938 PF-5190457 DB14870
0.3931 Alpelisib DB12015
0.3904 Faldaprevir DB11808